One of the fastest growing heart valve company in the world.
MicroPort CardioFlow established in 2015, is dedicated to providing advanced minimally invasive therapies for structural heart diseases. Our vision, is to bring cutting edge technologies into treatment development, in order to optimize clinical outcomes, and improve patients’ quality of life, with reliable, superior and accessible solutions. We are driven by 3 aspects:
VitaFlow™ Aortic Valve System
More Precision, More Durability, More Freedom
VitaFlow™ Aortic Valve, uses bovine pericardial leaflets to provide enhanced valve durability, its innovative frame and skirt designs deliver reliable hemodynamic performance, and dependable clinical outcomes for patients.
Bovine Valve with Vital-X™ Anti-calcification Treatment
VitaFlow™ Aortic Valve features a proprietary Vital-X™ technology which extracts phospholipids and cholesterol from pericardial leaflets, which stabilizes collagen formation. This prevents valve leaflets from calcification, minimizes structural valve deterioration, and prolongs valve durability.
Hybrid Density Frame with PET Skirts
Reduced risk for Para-valvular Leak
VitalFlow Delivery System
VitalFlow™ Delivery System with an exclusive design specialized for stable and accurate delivery of the VitaFlow™ Aortic Valve, its proprietary motorized handle allows for the precise controlling of the guidewire while deploying the valve by a single operator.